| Executive Committee 2014 – 2018 | |
| President: | S.J. Enna, USA |
| Secretary-General: | Michael Spedding, France |
| Treasurer: | Petra Thurmann, Germany |
| First Vice-President: | Graeme Henderson, United Kingdom |
| Second Vice-President: | Masamitsu Iino, Japan |
| Councilors: | James Barrett, USA Francesa Levi-Schaffer, Israel Eeva Moilanen, Finland Bhagirath Patel, India Yongxiang Zhang, China |
| Executive Committee 2010 – 2014 | |
| President: | Patrick du Souich, Canada |
| Secretary-General: | S.J. Enna, USA |
| Treasurer: | Urs Ruegg, Switzerland |
| First Vice-President: | Graeme Henderson, United Kingdom |
| Second Vice-President: | Masamitsu Iino, Japan |
| Councilors: | Kim Brøsen, Denmark Kay Brune, Germany John O. Miners, Australia Douglas Oliver, South Africa Yongxiang Zhang, China |
| Past President: | Sue Piper Duckles, USA |
| Chair of the Division on Clinical Pharmacology: | Donald J. Birkett, Australia |
| Vice-Chair of the Division on Clinical Pharmacology: | Darrell Abernethy, United States |
| Representatives of the Division on Clinical Pharmacology: | Petra Thürmann, Germany María Isabel Lucena, Spain |
| Auditors: | Christiaan Brink, South Africa Garret FitzGerald, United States |
| Executive Committee 2006 – 2010 | |
| President: | Sue Piper Duckles, USA |
| Secretary-General: | S.J. Enna, USA |
| Treasurer: | Urs Ruegg, Switzerland |
| First Vice-President: | Salomon Z Langer, Israel |
| Second Vice-President: | Masayoshi Mishina, Japan |
| Councilors: | Kim Brøsen, Denmark Sérgio H. Ferreira, Brazil Gabrielle Hawksworth, UK Mohamed T. Khayyal, Egypt Zhi-Bin Lin, China |
| Past President: | Paul M. Vanhoutte, Hong Kong |
| Chair of the Division on Clinical Pharmacology: | Patrick du Souich, Canada |
| Vice-Chair of the Division on Clinical Pharmacology: | Donald J. Birkett, Australia |
| Representatives of the Division on Clinical Pharmacology: | Petra Thürmann, Germany María Isabel Lucena, Spain |
| Auditors: | Kay Brune, Germany Douglas Oliver, South Africa |
